- Stocks
- Healthcare
- NYSE: BSX

Price (delayed)

$37.15

Market cap

$53.15B

P/E Ratio

12.99

Dividend/share

N/A

EPS

$2.86

Enterprise value

$60.96B

BSX's quick ratio has surged by 168% year-on-year and by 108% since the previous quarter

The P/E is 87% below the 5-year quarterly average of 101.1 and 41% below the last 4 quarters average of 21.9

Boston Scientific's net income has surged by 185% YoY but it has decreased by 7% QoQ

The EPS has soared by 183% YoY but it has decreased by 7% from the previous quarter

Boston Scientific's gross profit has decreased by 9% QoQ and by 3.6% YoY

The revenue has decreased by 6% from the previous quarter

What are the main financial stats of BSX

Market
Valuations
Earnings

Shares outstanding

1.43B

Market cap

$53.15B

Enterprise value

$60.96B

Price to earnings (P/E)

12.99

Price to book (P/B)

3.33

Price to sales (P/S)

5.16

EV/EBIT

160.41

EV/EBITDA

43.82

EV/Sales

6

Revenue

$10.16B

EBIT

$380M

EBITDA

$1.39B

Free cash flow

$1.02B

Per share
Balance sheet
Liquidity

EPS

$2.86

Free cash flow per share

$0.72

Book value per share

$11.16

Revenue per share

$7.2

TBVPS

$9.61

Total assets

$30.82B

Total liabilities

$15.21B

Debt

$9.53B

Equity

$15.62B

Working capital

$2.7B

Debt to equity

0.61

Current ratio

1.87

Quick ratio

1.02

Net debt/EBITDA

5.61

Margins
Efficiency
Dividend

EBITDA margin

13.7%

Gross margin

68.2%

Net margin

39.2%

Operating margin

6.6%

Return on assets

13.5%

Return on equity

30%

Return on invested capital

2.2%

Return on capital employed

1.4%

Return on sales

3.7%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Boston Scientific stock price performed over time

How have Boston Scientific's revenue and profit performed over time

Revenue

$10.16B

Gross profit

$6.93B

Operating income

$669M

Net income

$3.99B

Gross margin

68.2%

Net margin

39.2%

Boston Scientific's net income has surged by 185% YoY but it has decreased by 7% QoQ

Boston Scientific's net margin has surged by 182% YoY

BSX's operating margin has dropped by 59% year-on-year and by 37% since the previous quarter

Boston Scientific's operating income has plunged by 59% YoY and by 40% from the previous quarter

What is Boston Scientific's growth rate over time

What is Boston Scientific stock price valuation

P/E

12.99

P/B

3.33

P/S

5.16

EV/EBIT

160.41

EV/EBITDA

43.82

EV/Sales

6

The EPS has soared by 183% YoY but it has decreased by 7% from the previous quarter

The P/E is 87% below the 5-year quarterly average of 101.1 and 41% below the last 4 quarters average of 21.9

The equity has soared by 66% YoY and by 13% from the previous quarter

The stock's price to book (P/B) is 33% less than its 5-year quarterly average of 5.0 and 21% less than its last 4 quarters average of 4.2

BSX's P/S is 15% above its 5-year quarterly average of 4.5

The revenue has decreased by 6% from the previous quarter

How efficient is Boston Scientific business performance

The return on assets has surged by 118% year-on-year but it has declined by 12% since the previous quarter

The return on equity has surged by 91% year-on-year but it has declined by 18% since the previous quarter

BSX's ROIC has plunged by 86% YoY and by 49% from the previous quarter

The ROS has plunged by 78% YoY and by 43% from the previous quarter

What is BSX's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for BSX.

How did Boston Scientific financials performed over time

Boston Scientific's total assets is 103% more than its total liabilities

BSX's quick ratio has surged by 168% year-on-year and by 108% since the previous quarter

BSX's current ratio has surged by 55% since the previous quarter and by 43% year-on-year

Boston Scientific's debt is 39% lower than its equity

The equity has soared by 66% YoY and by 13% from the previous quarter

Boston Scientific's debt to equity has decreased by 40% YoY and by 19% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.